115 related articles for article (PubMed ID: 11958663)
1. Lack of HER-2/neu expression in Hodgkin and non-Hodgkin lymphoma.
Bairey O; Pazgal I; Okon E; Shaklai M; Morgenshtern S
Arch Pathol Lab Med; 2002 May; 126(5):574-6. PubMed ID: 11958663
[TBL] [Abstract][Full Text] [Related]
2. Lack of HER-2/neu overexpression in non-Hodgkin's lymphoma.
Lüftner D; Genvresse I; Geppert R; Kaufmann O; Dietel M; Possinger K
Anticancer Res; 2004; 24(5B):3233-7. PubMed ID: 15510616
[TBL] [Abstract][Full Text] [Related]
3. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of HER-2/neu oncoprotein overexpression in invasive breast cancer by image analysis: a study comparing fresh and paraffin-embedded material.
van Diest PJ; Baak JP; Chin D; Theeuwes JW; Bacus SS
Anal Cell Pathol; 1991 Jul; 3(4):195-202. PubMed ID: 1679345
[TBL] [Abstract][Full Text] [Related]
5. Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B).
Murphy D; Parker J; Zhou M; Fadlelmola FM; Steidl C; Karsan A; Gascoyne RD; Chen H; Banerjee D
Mol Cancer; 2010 Jan; 9():14. PubMed ID: 20100355
[TBL] [Abstract][Full Text] [Related]
6. HER-2/Neu overexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancer.
Tulbah AM; Ibrahim EM; Ezzat AA; Ajarim DS; Rahal MM; El Weshi AN; Sorbris R
Med Oncol; 2002; 19(1):15-23. PubMed ID: 12025887
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of BCL-3 in lymphoid neoplasms: a survey of 353 cases.
Canoz O; Rassidakis GZ; Admirand JH; Medeiros LJ
Mod Pathol; 2004 Aug; 17(8):911-7. PubMed ID: 15105810
[TBL] [Abstract][Full Text] [Related]
8. Association of HER-2/neu overexpression with the number of involved axillary lymph nodes in hormone receptor positive breast cancer patients.
Tokatli F; Altaner S; Uzal C; Ture M; Kocak Z; Uygun K; Bilgi S
Exp Oncol; 2005 Jun; 27(2):145-9. PubMed ID: 15995634
[TBL] [Abstract][Full Text] [Related]
9. Histamine content in lymph nodes from patients with malignant lymphomas.
Belcheva A; Mishkova R
Inflamm Res; 1995 Apr; 44 Suppl 1():S86-7. PubMed ID: 8521017
[No Abstract] [Full Text] [Related]
10. Expression of the monomeric 67-kd laminin-binding protein in human lymphomas as defined by MLuC5 monoclonal antibody and paraffin section immunohistochemistry.
Carbone A; Gloghini A; Colombatti A; Castronovo V; Ménard S
Hum Pathol; 1995 May; 26(5):541-6. PubMed ID: 7750938
[TBL] [Abstract][Full Text] [Related]
11. HER-2/neu overexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real-time reverse transcription-polymerase chain reaction, and fluorescence in situ hybridization.
Odicino FE; Bignotti E; Rossi E; Pasinetti B; Tassi RA; Donzelli C; Falchetti M; Fontana P; Grigolato PG; Pecorelli S
Int J Gynecol Cancer; 2008; 18(1):14-21. PubMed ID: 17451461
[TBL] [Abstract][Full Text] [Related]
12. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Profile of Hodgkin and Non-Hodgkin Lymphoma.
Shahid R; Gulzar R; Avesi L; Hassan S; Danish F; Mirza T
J Coll Physicians Surg Pak; 2016 Feb; 26(2):103-7. PubMed ID: 26876395
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression.
Bhargava R; Naeem R; Marconi S; Luszcz J; Garb J; Gasparini R; Otis CN
Hum Pathol; 2001 Dec; 32(12):1344-50. PubMed ID: 11774167
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of Epstein-Barr virus infection and childhood lymphoma].
Xie ZD; Wang L; Lu D; Zhou CJ; Shen KL
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):365-7. PubMed ID: 18953837
[TBL] [Abstract][Full Text] [Related]
16. p53 expression in lymphatic malignancies.
Soini Y; Pääkkö P; Alavaikko M; Vähäkangas K
J Clin Pathol; 1992 Nov; 45(11):1011-4. PubMed ID: 1452775
[TBL] [Abstract][Full Text] [Related]
17. Cytophotometric measurements of the DNA in Hodgkin lymphomas and non-Hodgkin lymphomas.
Adler CP; Riede UN; Wurdak W; Zugmaier G
Pathol Res Pract; 1984 Jul; 178(6):579-89. PubMed ID: 6207516
[TBL] [Abstract][Full Text] [Related]
18. Gene amplification and protein overexpression of HER-2/neu in human extrahepatic cholangiocarcinoma as detected by chromogenic in situ hybridization and immunohistochemistry: its prognostic implication in node-positive patients.
Kim HJ; Yoo TW; Park DI; Park JH; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim MK; Chae SW; Sohn JH
Ann Oncol; 2007 May; 18(5):892-7. PubMed ID: 17322545
[TBL] [Abstract][Full Text] [Related]
19. HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system.
Ciampa A; Xu B; Ayata G; Baiyee D; Wallace J; Wertheimer M; Edmiston K; Khan A
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):132-7. PubMed ID: 16785779
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of HER-2/neu expression in prostatic adenocarcinoma: a requested for a standardized, organ specific methodology.
Sanchez KM; Sweeney CJ; Mass R; Koch MO; Eckert GJ; Geary WA; Baldridge LA; Zhang S; Eble JN; Cheng L
Cancer; 2002 Oct; 95(8):1650-5. PubMed ID: 12365012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
